ClinicalTrials.Veeva

Menu

HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults

U

University of Coimbra

Status

Completed

Conditions

Depressive Symptoms
Mild Cognitive Impairment
Anxiety State

Treatments

Behavioral: HEPPI

Study type

Interventional

Funder types

Other

Identifiers

NCT05499767
HEPPIEfficacy/CINEICC
SFRH/BD/146170/2019 (Other Grant/Funding Number)

Details and patient eligibility

About

The main goal of this research is to assess the efficacy of a 10-week home-delivered cognitive-emotional intervention program for homebound older adults presenting Mild Cognitive Impairment (MCI) and depressive and/or anxiety symptoms. The Homebound Elderly People Psychotherapeutic Intervention (HEPPI) combines cognitive training, psychotherapeutic techniques, and compensatory strategy training, and was designed to optimize memory function and to reduce depressive or anxious symptomatology of these older adults.

A two-arm randomized controlled trial (RCT) is conducted to investigate the efficacy of the HEPPI among the homebound older population.

Full description

The present study aims to assess the efficacy of a cognitive-emotional intervention (the HEPPI program) for homebound older adults with MCI and depressive and/or anxious symptomatology.

The research design of the trial followed the methodological recommendations for conducting goropsychoterapy research. Moreover, a pilot RCT was conducted prior to the present RCT, in order to assess the feasibility, acceptability, and preliminary efficacy of the HEPPI. Appropriate adjustments to the HEPPI protocol were carried out considering the results.

The present study is a two-arm RCT comparing the intervention condition (HEPPI) to a treatment as usual (TAU) control group. The sample includes community-dwelling older adults who do not leave home more often than once a week. Homebound older adults are recruited from the community through contact with their health care networks. A minimum number of 79 participants per condition will be required (N=158). Accounting for an expected 20% attrition rate, an anticipated sample of 198 participants will be enrolled in the study. Participants who demonstrate interest in the study are informed of the goals and procedures of the research and asked to provide informed consent before eligibility assessment. Eligible participants are randomly assigned to the HEPPI or the TAU group.

Homebound older adults are asked to complete baseline, post-intervention, and 3-month follow-up assessments. Assessments include neuropsychological tests to assess cognition function, psychological health, subjective memory complaints, quality of life, functional status, perceived loneliness, and personality. The study procedures take place at the participants' homes.

Enrollment

199 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Homebound older adults aged 65 years and older;
  • MoCA score 1 to 1.5 standard deviation below the mean for age- and education- adjusted norms;
  • FCSRT total immediate and delayed recall scores ≤ 35 and ≤ 12, respectively;
  • Presence of subjective memory complaints (SMCS score ≥ 3);
  • Presence of depressive symptomatology (GDS-30 score ≥ 11);
  • Presence of anxious symptomatology (GAI score ≥ 8);
  • No significant impact from cognitive impairment on daily functional capacity;
  • Residence in mainland Portugal;

Exclusion criteria

  • Presence or history of significant neurological conditions;
  • Presence of severe psychiatric illnesses;
  • Presence of comorbid medical conditions associated with cognition decline;
  • Use of psychotropic medication for less than three months;
  • Presence of alcoholism or toxicomania;
  • Significant impairment of vision, hearing, communication, or manual dexterity.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

199 participants in 2 patient groups

HEPPI
Experimental group
Description:
The HEPPI group attends weekly 90-minute intervention sessions at the participants' homes.
Treatment:
Behavioral: HEPPI
Treatment as Usual (TAU)
No Intervention group
Description:
The TAU group receives access to HEPPI at the end of the study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems